Fibrinolytic profile depends on disease severity in pediatric patients with cirrhosis: illustration by 2 different plasma-based fibrinolysis assays

• Marie-Astrid van Dievoet,
• Karim Zouaoui Boudjeltia,
• Madeleine Rousseaux,
• Jonathan Douxfils,
• Ton Lisman,
• Xavier Stephenne

Affiliations

Marie-Astrid van Dievoet

Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium; Laboratory Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium; Correspondence Marie-Astrid van Dievoet, Laboratory Department, Cliniques Universitaires Saint-Luc, 54 Avenue Hippocrate, B-1200 Brussels, Belgium.

Karim Zouaoui Boudjeltia

Laboratory of Experimental Medicine (Univeristé libre de Bruxelles, 222 Unit), Faculty of Medicine, Centre Hospitalier Universitaire de Charleroi, André Vésale Hospital, Université Libre de Bruxelles, Montigny-le-Tilleul, Belgium

Madeleine Rousseaux

Laboratory Department, Cliniques Universitaires Saint-Luc, Brussels, Belgium

Jonathan Douxfils

Clinical Pharmacology and Toxicology Research Unit, Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium; Research and Development Deparment, QUALIblood s.a., QUALIresearch, Liège, Belgium

Ton Lisman

Surgical Research Laboratory and Section of Hepatobiliary Surgery and Liver Transplantation, Deparment of Surgery, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands

Xavier Stephenne

Laboratory of Pediatric Hepatology and Cell Therapy, Institut de Recherche Expérimentale et Clinique (IREC), Université Catholique de Louvain, Brussels, Belgium; Division of Pediatric Gastroenterology and Hepatology, Department of Pediatrics, Cliniques Universitaires Saint-Luc, Rare Liver European Reference Network, TransplantChild European Reference Network, Brussels, Belgium